Intercellular skin barrier lipid composition and organization in netherton syndrome patients

Journal of Investigative Dermatology

Volumn 134, Issue 5, 2014, Pages 1238-1245

  Van Smeden, Jeroen ^a   Janssens, Michelle ^a   Boiten, Walter A ^a   Van Drongelen, Vincent ^a,b   Furio, Laetitia ^c,d,e   Vreeken, Rob J ^a   Hovnanian, Alain ^c,d,e   Bouwstra, Joke A ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c INSERM   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; LIPID; MONOUNSATURATED FATTY ACID; FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; LIPID COMPOSITION; MASS SPECTROMETRY; MOUSE; NETHERTON DISEASE; NONHUMAN; PROTEIN EXPRESSION; STRATUM CORNEUM; X RAY DIFFRACTION; LIPID ANALYSIS; LIPID BILAYER; PRIORITY JOURNAL; PROTEIN MODIFICATION;

ADOLESCENT; ADULT; BODY WATER; CERAMIDES; CHILD; DERMATITIS, ATOPIC; EPIDERMIS; FATTY ACIDS; FATTY ACIDS, NONESTERIFIED; FATTY ACIDS, UNSATURATED; FEMALE; GLUCOSYLCERAMIDASE; GLUCOSYLTRANSFERASES; HUMANS; MALE; NETHERTON SYNDROME; SPHINGOMYELIN PHOSPHODIESTERASE; YOUNG ADULT;

EID: 84900874438     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2013.517     Document Type: Article

References (46)

1. Bitoun E, Chavanas S, Irvine AD et al. (2002) Netherton syndrome: Disease expression and spectrum of SPINK5 mutations in 21 families. J Invest Dermatol 118:352-61
2. Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911-7
3. Bonnart C, Deraison C, Lacroix M et al. (2010) Elastase 2 is expressed in human and mouse epidermis and impairs skin barrier function in Netherton syndrome through filaggrin and lipid misprocessing. J Clin Invest 120:871-82
4. Bouwstra JA, Gooris GS, Cheng K et al. (1996) Phase behavior of isolated skin lipids. J Lipid Res 37:999-1011
5. Bouwstra JA, Gooris GS, Dubbelaar FE et al. (2001) Phase behavior of lipid mixtures based on human ceramides: Coexistence of crystalline and liquid phases. J Lipid Res 42:1759-70
6. Bouwstra JA, Gooris GS, van der Spek JA et al. (1991) Structural investigations of human stratum corneum by small-Angle X-ray scattering. J Invest Dermatol 97:1005-12
7. Bras W, Dolbnya IP, Detollenaere D et al. (2003) Recent experiments on a combined small-Angle/wide-Angle X-ray scattering beam line at the ESRF. J Appl Crystallogr 36:791-4
8. Chavanas S, Bodemer C, Rochat A et al. (2000) Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet 25:141-2
9. De Jager M, Groenink W, Bielsa i et al. (2006) A novel in vitro percutaneous penetration model: Evaluation of barrier properties with p-Aminobenzoic acid and two of its derivatives. Pharm Res 23:951-60
10. Deraison C, Bonnart C, Lopez F et al. (2007) LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pHdependent interaction. Mol Biol Cell 18:3607-19
11. Di Nardo A, Wertz P, Giannetti A et al. (1998) Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. Acta Derm Venereol 78:27-30
12. Di WL, Hennekam RC, Callard RE et al. (2009) A heterozygous null mutation combined with the G1258A polymorphism of SPINK5 causes impaired LEKTI function and abnormal expression of skin barrier proteins. Br J Dermatol 161:404-12
13. Eckl KM, Tidhar R, Thiele H et al. (2013) Impaired epidermal ceramide synthesis causes autosomal recessive congenital ichthyosis and reveals the importance of ceramide acyl chain length. J Invest Dermatol 133:2202-11
14. Elias PM (2010) Therapeutic Implications of a barrier-based pathogenesis of atopic dermatitis. Ann Dermatol 22:245-54
15. Fartasch M, Bassukas ID, Diepgen TL (1992) Disturbed extruding mechanism of lamellar bodies in dry non-eczematous skin of atopics. Br J Dermatol 127:221-7
16. Fartasch M, Williams ML, Elias PM (1999) Altered lamellar body secretion and stratum corneum membrane structure in Netherton syndrome: Differentiation from other infantile erythrodermas and pathogenic implications. Arch Dermatol 135:823-32
17. Farwanah H, Pierstorff B, Schmelzer CEH et al. (2007) Separation and mass spectrometric characterization of covalently bound skin ceramides using LC/APCI-MS and nano-ESI-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 852:562-70
18. Greene SL, Muller SA (1985) Netherton's syndrome. Report of a case and review of the literature. J Am Acad Dermatol 13:329-37
19. Groen D, Poole DS, Gooris GS et al. (2011) Is an orthorhombic lateral packing and a proper lamellar organization important for the skin barrier function? Biochim Biophys Acta 1808:1529-37
20. Hachem JP, Crumrine D, Fluhr J et al. (2003) pH directly regulates epidermal permeability barrier homeostasis, and stratum corneum integrity/cohesion. J Invest Dermatol 121:345-53
21. Hachem JP, Man MQ, Crumrine D et al. (2005) Sustained serine proteases activity by prolonged increase in pH leads to degradation of lipid processing enzymes and profound alterations of barrier function and stratum corneum integrity. J Invest Dermatol 125:510-20
22. Hachem JP, Wagberg F, Schmuth M et al. (2006) Serine protease activity and residual LEKTI expression determine phenotype in Netherton syndrome. J Invest Dermatol 126:1609-21
23. Hausser I, Anton-Lamprecht I (1996) Severe congenital generalized exfoliative erythroderma in newborns and infants: A possible sign of Netherton syndrome. Pediatr Dermatol 13:183-99
24. Hausser I, Anton-Lamprecht I, Hartschuh W et al. (1989) Netherton's syndrome: Ultrastructure of the active lesion under retinoid therapy. Arch Dermatol Res 281:165-72
25. Hitomi K (2005) Transglutaminases in skin epidermis. Eur J Dermatol 15:313-9
26. Imokawa G, Abe A, Jin K et al. (1991) Decreased level of ceramides in stratum corneum of atopic dermatitis: An etiologic factor in atopic dry skin? J Invest Dermatol 96:523-6
27. Ishikawa J, Narita H, Kondo N et al. (2010) Changes in the ceramide profile of atopic dermatitis patients. J Invest Dermatol 130:2511-4
28. Janssens M, van Smeden J, Gooris GS et al. (2012) Increase in shortchain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients. J Lipid Res 53:2755-66
29. Krol A, Krafchik B (2006) The differential diagnosis of atopic dermatitis in childhood. Dermatol Ther 19:73-82
30. Masukawa Y, Narita H, Sato H et al. (2009) Comprehensive quantification of ceramide species in human stratum corneum. J Lipid Res 50:1708-19
31. Mauro T (2006) SC pH: Measurement, origins, and functions. In: Elias PM, Feingold KR (eds) ''Skin Barrier''. Taylor & Francis: New York, xviii 612.
32. Meguro S, Arai Y, Masukawa Y et al. (2000) Relationship between covalently bound ceramides and transepidermal water loss (TEWL). Arch Dermatol Res 292:463-8
33. Moskowitz DG, Fowler AJ, Heyman MB et al. (2004) Pathophysiologic basis for growth failure in children with ichthyosis: An evaluation of cutaneous ultrastructure, epidermal permeability barrier function, and energy expenditure. J Pediatr 145:82-92
34. Norlen L, Nicander I, Lundsjo A et al. (1998) A new HPLC-based method for the quantitative analysis of inner stratum corneum lipids with special reference to the free fatty acid fraction. Arch Dermatol Res 290:508-16
35. Park YH, Jang WH, Seo JA et al. (2012) Decrease of ceramides with very longchain fatty acids and downregulation of elongases in a murine atopic dermatitis model. J Invest Dermatol 132:476-9
36. Pilgram GS, Engelsma-van Pelt AM, Bouwstra JA et al. (1999) Electron diffraction provides new information on human stratum corneum lipid organization studied in relation to depth and temperature. J Invest Dermatol 113:403-9
37. Ponec M, Gibbs S, Pilgram G et al. (2001) Barrier function in reconstructed epidermis and its resemblance to native human skin. Skin Pharmacol Appl Skin Physiol 14(Suppl 1):63-71
38. Pruszkowski A, Bodemer C, Fraitag S et al. (2000) Neonatal and infantile erythrodermas: A retrospective study of 51 patients. Arch Dermatol 136:875-80
39. Raghunath M, Tontsidou L, Oji V et al. (2004) SPINK5 and Netherton syndrome: Novel mutations, demonstration of missing LEKTI, and differential expression of transglutaminases. J Invest Dermatol 123:474-83
40. Sassa T, Ohno Y, Suzuki S et al. (2013) Impaired epidermal permeability barrier in mice lacking elovl1, the gene responsible for very-long-chain fatty acid production. Mol Cell Biol 33:2787-96
41. Smith DL, Smith JG, Wong SW et al. (1995) Netherton's syndrome: A syndrome of elevated IgE and characteristic skin and hair findings. J Allergy Clin Immunol 95:116-23
42. Sun JD, Linden KG (2006) Netherton syndrome: A case report and review of the literature. Int J Dermatol 45:693-7
43. Thakoersing VS, van Smeden J, Mulder AA et al. (2013) Increased presence of monounsaturated fatty acids in the stratum corneum of human skin equivalents. J Invest Dermatol 133:59-67
44. van Smeden J, Hoppel L, van der Heijden R et al. (2011) LC/MS analysis of stratum corneum lipids: Ceramide profiling and discovery. J Lipid Res 52:1211-21
45. van Smeden J, Boiten WA, Hankemeier T et al. (2014) Combined LC/MSplatform for analysis of all major stratum corneum lipids, and the profiling of skin substitutes. Biochim Biophys Acta 1841:70-9
46. van Smeden J, Janssens M, Kaye E et al. (2013) The importance of free fatty acid chain length for the skin barrier function in atopic eczema patients. Exp Dermatol 23:45-52